Anupam Rasayan Share Price

Anupam Rasayan India Limited, together with its subsidiaries, is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India, with a focused presence in Life Science related specialty chemicals and Performance Materials. The company operates through two verticals: Life Science related Specialty Chemicals (comprising products for agrochemicals, personal care, and pharmaceuticals) and Other Specialty Chemicals (comprising polymer additives). It caters to a diverse base of Indian and global customers through multi-step synthesis and complex technologies.

The Anupam Rasayanshare pricetoday on the NSE and BSE is a reflection of how market participants respond to a company’s performance and broader business developments within its industry. It captures the sentiment of the investors based on financial results, operational updates, macroeconomic factors, and trends specific to sectors. Movements in the share price͏ reveal how the market evaluates the company’s current position and its future prospects, making ͏it a key indicator of market perception across various industries.

Market sentiment around the Anupam Rasayanstock price often mirrors shifts in demand for agrochemicals, pharmaceuticals, and performance materials, as well as investor views on the specialty chemicals sector’s growth prospects. Factors such as the pace of new product introductions, competitive intensity, raw material cost inflation, and changing customer preferences influence near-term market valuation and medium-term earnings forecasts.All these factors must be closely monitored to have an idea about theAnupam Rasayanstock price movements.

Anupam Rasayanlive share price provides real-time information about the last price traded, bid price, ask price, and volume traded. These indicators represent trading activity and liquidity and the reaction of investors to corporate announcements, quarterly results, and sector news. Constant ͏monitoring ofAnupam Rasayanlive price helps observe short-term price fluctuations and understand how the stock is moving in relation to the broader market.

Furthermore, monitoring theAnupam Rasayanshare͏ price today helps investors understand real-time market sentiment, price volatility, and trading behaviour. It allows market participants to evaluate short-term performance, identifypossible entry or exit points, and respond to news, quarterly results or sector trends that may affect the company’s valuation and overall investment outlook.

Anupam Rasayan India Limited Company Fundamentals

a. Company Background

Anupam Rasayan India Limited is an Indian specialty chemicals company engaged in the custom synthesis and manufacturing of specialty chemicals for agrochemical, personal care, pharmaceutical, and polymer sectors. It was initially formed as a partnership firm named Anupam Rasayan effective from April 1, 1984, at Surat in Gujarat, which was registered under the Indian Partnership Act, 1932, on October 22, 1984. The partnership firm was subsequently converted into a joint stock company and registered as a public limited company under the name Anupam Rasayan India Limited on September 30, 2003, issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. The company received its Certificate of Commencement of Business on November 20, 2003. The company has its registered office at Surat, Gujarat, India. Anupam Rasayanis widely recognized for its expertise in custom synthesis and manufacturing of specialty chemicals, focusing on Life Science related specialty chemicals and Performance Materials. The company operates six manufacturing facilities in Gujarat, with four located at Sachin, Surat, and two at Jhagadia, Bharuch, with an aggregate installed capacity of about 30,000 MT as of March 31, 2025. The company is also one of the few in India manufacturing products using continuous and flow chemistry technology on a commercial scale. It operates within India’s growing specialty chemicals industry, driven by increasing demand for agrochemicals, pharmaceuticals, and performance materials from global and domestic customers.

b. Product Lines

• Life Science related Specialty Chemicals: agrochemicals (crop protection products including insecticides, fungicides, herbicides), personal care intermediates and ingredients, pharmaceutical intermediates and active pharmaceutical ingredients (APIs)

• Other Specialty Chemicals: polymer additives, specialty pigments and dyes, electronic chemicals, high-performance specialty chemicals for critical polymer applications

• Custom synthesis and manufacturing (CSM) services including multi-step synthesis and complex chemical reactions

• Fluorine and non-fluorine chemistry-based products for agrochemical, pharmaceutical, and polymer sectors

• Key starting materials (KSMs) and intermediates for crop protection and pharmaceutical industries

• Specialty chemicals for personal care applications

c. Company Revenue Model

• Primary revenue from the Life Science related Specialty Chemicals segment (agrochemicals, personal care, pharmaceuticals)

• Revenue from the Other Specialty Chemicals segment (polymer additives, specialty pigments and dyes)

• Revenue from custom synthesis and manufacturing services for global and domestic customers

• Revenue from export of specialty chemicals to international markets across Europe, Japan, Singapore, China, North America, and other regions

• Revenue from subsidiary operations including Tanfac Industries Limited

• Income from manufacturing of specialty chemicals using continuous and flow chemistry technology

• Revenue from multi-step synthesis and complex chemical reactions for diverse customer base

d. Geographic Presence

• Registered office located in Surat, Gujarat, India, with corporate presence in Mumbai, India

• Strong pan-India presence with six manufacturing facilities located in Gujarat, with four at Sachin, Surat, and two at Jhagadia, Bharuch

• International presence across USA, Europe, Japan, Dubai, and Singapore through global customer relationships

• Export operations to Europe (since 1999), Singapore (since 2010), Japan, China, and North America (since 2021)

• Delivery model leveragesstate-of-the-art manufacturing facilities with glass-lined, titanium cladded, and stainless steel reactors

• Proximity to Adani Hazira Port for export-oriented operations reducing freight and logistics costs

e. Key Milestones

• 1984: Started as partnership firm M/S Anupam Rasayanon April 1, 1984

• 1999: Began export operations to Europe

• 2003: Converted into a public limited company on September 30, 2003

• 2010: Began export orders to Singapore

• 2014: Commissioned Unit 4 in Jhagadia GIDC

• 2016: Conferred the Green Innovation Award by Corning Reactor Technology; secured funds from Dr Kiran Patel

• 2019: Commissioned Unit 5 in Jhagadia GIDC and Unit 6 in Sachin GIDC

• 2021: Listed on NSE and BSE in March 2021; commissioned 12.5 MW solar power plant at Bharuch; started export orders to North America

• 2022: Acquired stake and management control in Tanfac Industries Limited; commissioned 5.4 MW solar power plant at Bharuch

• 2024: Secured funds through preferential allotment; committed to expanding renewable portfolio with 9.6 MW hybrid project

• 2025: Signed definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the USA

f. Industry Perspective: Specialty Chemicals Industry in India

Anupam Rasayan operates in the global and Indian specialty chemicals industry. Globally, specialty chemistries account for 20% of total global chemistries worth $4 trillion, with India’s market projected to grow to $64 billion by 2025. India’s specialty chemicals industry is one of the fastest-growing in the world, with a growth CAGR of 11-12% compared to the global 5-6%. The India specialty chemicals market size reached USD 67.0 billion in 2025 and is expected to reach USD 93.4 billion by 2034, exhibiting a growth rate (CAGR) of 3.65% during 2026-2034. The broader Indian chemical market is currently valued at $220 billion and is projected to reach $383 billion by 2030, reflecting a CAGR of 8.1% from 2021 to 2030. Key growth drivers include increasing demand from end-user industries (agrochemicals, pharmaceuticals, personal care, polymers), government initiatives such as the Production Linked Incentive (PLI) scheme and Petroleum, Chemicals, and Petrochemicals Investment Regions (PCPIR) policy, and the shift towards domestic manufacturing under the ‘Make in India’ initiative. The industry faces challenges including raw material price volatility, global economic uncertainty, intense competition from international players, and environmental compliance requirements. The industry outlook remains positive, supported by sustained government focus on manufacturing, increasing domestic consumption, and growing export opportunities.

Anupam Rasayan India Limited Stock Market Presence: Listings & Index Representation

Anupam Rasayan India Limited is actively traded on India’s principal equity markets, with its shares listed on the National Stock Exchange of India (NSE) under the symbol ANURAS and on the Bombay Stock Exchange (BSE) with the scrip code 543275. The ISIN number of the company’s equity shares is INE930P01018. The company was listed on the NSE and BSE on March 24, 2021, following its IPO. Its listing on both exchanges ensures that the Anupam Rasayanshare priceis accessible to a wide investor base, encompassing both retail and institutional market participants. The company forms part of several benchmark indices that represent broad market segments. Anupam Rasayanis included in indices such as the BSE 500, BSE AllCap, BSE SmallCap, BSE Chemicals, Nifty Microcap 250, and Nifty Smallcap 250. These index participations signal the company‘s relevance within market categories that attract both active and passive investment flows. Being represented in multiple indices enhances the visibility and liquidity of the Anupam Rasayanstock price, as index tracking funds and exchange traded strategies often adjust allocations in line with constituent revisions. It also allows investors to benchmark the company’s stock performance relative to broader market trends and peer groups, facilitating cross sectional comparisons within India‘s specialty chemicals landscape. The inclusion of Anupam Rasayanin these indices reflects its market capitalisation and trading depth, which are key factors market participants consider when evaluating long term investment prospects and the responsiveness of the stock price to corporate and industry developments.

Anupam Rasayan India Limited Stock Performance and Share Price History

The Anupam Rasayanshare pricehas displayed significant volatility since its listing in March 2021, shaped by the company’s financial performance, specialty chemicals cycles, and broader market trends. The Anupam Rasayanshare pricemade a strong debut, listing at a premium. The Anupam Rasayanshare pricereached a 52-week high of ₹1,405.00 and a 52-week low of ₹600.95, indicating a wide trading range and substantial price fluctuations. The Anupam Rasayanshare pricehas shown a 1-year absolute return that has fluctuated significantly, reflecting the volatility inherent in the specialty chemicals sector.

The Anupam Rasayanstock price has been particularly responsive to quarterly earnings releases and corporate announcements. When the company reported consolidated revenue of INR 1,730 crores for the nine months ended December 31, 2025, reflecting an 84% year-on-year growth, with EBITDA of INR 402 crores (up 53% YoY) and PAT of INR 166 crores (up 71% YoY), the Anupam Rasayanstock price showed a positive reaction. The Anupam Rasayanshare pricehas shown a pattern of strong positive momentum following strong earnings reports and strategic announcements. The Anupam Rasayanshare pricehas also been influenced by the company’s acquisition of a controlling stake in Tanfac Industries Limited and the definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the USA.

The Anupam Rasayanshare pricehas shown a YTD return that has varied significantly, while the 1-month and 3-month returns have shown fluctuations in line with market conditions. The Anupam Rasayanshare pricereached its 52-week high of ₹1,405.00 before declining to its 52-week low of ₹600.95, reflecting the volatility inherent in the specialty chemicals sector. The Anupam Rasayanshare pricehas shown average weekly movement of approximately 2.7-5%, indicating moderate price fluctuations compared to the chemicals industry average of 6.4%. Comprehending these patterns in the Anupam Rasayanshare priceis instrumental for investors seeking to contextualise long term performance trends vis à vis short term price dynamics, as the Anupam Rasayanstock price movements illustrate how industry fundamentals, demand cycles, raw material cost pressures, and investor expectations converge in market pricing.

Anupam Rasayan India Limited Investor Relevance and Role in Portfolio

Anupam Rasayan holds a distinctive position for portfolio investors who seek exposure to the Indian specialty chemicals sector with a focus on custom synthesis and life science-related products. The company’s diversified product portfolio across agrochemicals, pharmaceuticals, personal care, and polymer additives aligns it with investment strategies that value both domestic consumption growth and global export opportunities. The Anupam Rasayanshare priceoften mirrors how these themes resonate with investor portfolios, whereby both thematic and sector specific funds monitor demand from agrochemical and pharmaceutical end-markets when evaluating allocation decisions.

Institutional stakeholders play a moderate role in Anupam Rasayan’s ownership profile. The promoters held approximately 59.07% of the company as of December 2025, showing a stable trend. Mutual fund holders include Kiran Pallavi Investments LLC, and other institutional investors. Foreign Institutional Investors (FIIs) hold approximately 7.60% of the company as of December 2025. Domestic Institutional Investors (DIIs) hold approximately 0.33-0.42% of the company. Retail and other shareholders hold approximately 32.90% of the company. As of December 2025, promoters had approximately 15.99% of their shares pledged. Overall institutional holding in the company stands at approximately 8.02% as of December 2025.

Based on data, the beta for Anupam Rasayanhas been recorded at 1.37 in the long term (calculated on monthly ticks over 4 years), indicating that the stock has exhibited higher volatility than the broader market over extended periods. In the short-term daily analysis, beta values of -0.163 for the one-month range and 0.339 for the three-month range show mixed sensitivity to market fluctuations. Weekly data reveals a beta of 0.902 over one year and 0.614 over two years, indicating a gradual decline in volatility over longer durations. The 2-week beta over a two-year period stands at 0.748, reflecting moderate responsiveness, while the monthly beta over two years reaches 1.39, suggesting higher long-term volatility and stronger market linkage. The mean values across these periods range from 877.97 to 1,320.70, with standard deviations from 1.26 to 10.90, indicating higher price variability in longer periods. The Anupam Rasayanshare pricehas shown periods of heightened responsiveness to sector-specific news, quarterly earnings releases, and raw material price movements. The Anupam Rasayanshare pricereflects that the company’s position in the specialty chemicals sector may result in moderate to high price fluctuations. The Anupam Rasayanstock price is thus viewed as a growth-oriented opportunity within a portfolio context with varying volatility characteristics depending on the time frame.

Anupam Rasayan India Limited Sectoral Relevance and Peer Positioning

The sector relevance of Anupam Rasayanis anchored in its role within the broader Indian specialty chemicals industry, where it competes with other diversified chemical companies. As part of this industry, the company’s strategic positioning connects custom synthesis, life science-related specialty chemicals, and performance materials that serve multiple end-user segments. Competitors in adjacent segments include companies such as Aarti Surfactants Ltd., Aether Industries Ltd., Alkali Metals Ltd., Ami Organics Ltd., Archean Chemical Industries Ltd., Arvee Laboratories (India) Ltd., Camlin Fine Sciences Ltd., Chemcon Speciality Chemicals Ltd., ChemplastSanmar Ltd., and Fineotex Chemical Ltd.. Larger players such as Arkema, Clariant, Evonik, BASF, and AkzoNobel also compete in the global specialty chemicals space. Firms with parallels in either custom synthesis capabilities or product complexity are often referenced when evaluating relative performance and operational positioning within the sector.

In valuation terms, factors like the Anupam RasayanP/E ratio tend to reflect narrative shifts in earnings expectations and investor confidence relative to these peers. The Anupam RasayanP/E ratio has shown significant variation, standing at approximately 84.42 as of April 2026. Anupam Rasayanearnings history over the past several years has shown a pattern of consistent growth with recent moderation. Consolidated revenue for FY25 stood at approximately ₹1,312.20 crore, with net profit showing fluctuations. For Q2 FY26, revenue was INR 731 crores, up 149% year-on-year, with PAT of INR 57 crores, up 87% year-on-year. For the nine months ended December 31, 2025, consolidated revenue was INR 1,730 crores, up 84% year-on-year, with PAT of INR 166 crores, up 71% year-on-year. Anupam RasayanEPS has shown improvement in recent quarters, with Q2 FY26 PAT margin at 7.8% and first half PAT margin at 8.6%. Anupam Rasayanmarket cap has shown a pattern of growth since listing. The company’s market cap is approximately ₹14,731 crore as of April 2026. The company’s order book remains healthy at around ₹43,646 crores over five to seven years, with significant progress in commercializing products expected to contribute approximately ₹450 crores in revenue during FY26. This directional behaviour in valuation multiples demonstrates how market expectations around growth prospects and earnings durability influence broader assessment of the Anupam Rasayanshare pricewithin its industry context. The Anupam Rasayanstock priceremains a key barometer for the custom synthesis and specialty chemicals segment.

Over the last five years since its IPO in 2021, Anupam Rasayanmarket cap has shown a pattern of significant growth. The company’s market cap increased from lower levels at listing to approximately ₹14,731 crore as of April 2026. The market cap has shown a 5-year CAGR reflecting investor confidence in the company‘s custom synthesis capabilities and diversified product portfolio. The market cap has ranged between lower levels and its current value over the past five years, with a 52-week high and low reflecting the volatility in the specialty chemicals sector.

Anupam Rasayan earnings, in terms of net profit, have exhibited a pattern of growth followed by recent recovery. Net profit for Q2 FY26 stood at INR 57 crores, up 87% year-on-year. For the nine months ended December 31, 2025, consolidated PAT was INR 166 crores, up 71% year-on-year. Export revenue contributed 58% of total revenue in the nine months ended December 31, 2025. The company’s working capital days improved significantly from 409 days in FY25 to 247 days in H1 FY26, reflecting better operational efficiency.

Anupam Rasayan EPS history over the past five years has shown a pattern of improvement. PAT margin in Q2 FY26 was 7.8%, while first half FY26 PAT margin was 8.6%. The EPS showed improvement in recent quarters, reflecting the company‘s enhanced profitability on a per-share basis. The pharma segment contributed 19% of sales in the nine months ended December 31, 2025, while performance materials contributed 17% of revenue during the same period.

Anupam Rasayan P/E ratio history has shown a pattern of variation, fluctuating between moderate and elevated levels since its IPO. The P/E ratio stood at approximately 84.42 as of April 2026. The P/E ratio has ranged from lower levels in previous years to higher levels in recent periods, reflecting the market’s assessment of the company’s growth prospects. The current P/E ratio reflects that investor expectations remain anchored to the company‘s earnings growth trajectory and market position in the custom synthesis space.

Summary

Anupam Rasayan is a leading Indian specialty chemicals company listed on both the NSE and BSE, where the Anupam Rasayanshare pricereflects demand cycles in agrochemicals, pharmaceuticals, and personal care, as well as competitive dynamics within the specialty chemicals sector. Its representation in multiple stock indices supports market visibility, while investor interest is shaped by earnings trends, valuation narratives, and broader chemical consumption patterns. Within the sector, the company’s competitive context and earnings dynamics provide key perspectives on its role in the Indian specialty chemicals market.